G-CON selects Pall’s continuous bioprocessing and viral vector tech

By Flora Southey

- Last updated on GMT

(Image: Getty/Pattanaphong Khuankaew)
(Image: Getty/Pattanaphong Khuankaew)

Related tags Pall

G-CON Manufacturing has partnered with Pall Corporation to offer prefabricated cleanrooms for continuous bioprocessing and viral vector production.

According to the agreement, G-CON’s autonomous, mobile facilities, or ‘PODs’, can now be customised with Pall Biotech bioprocessing equipment.

G-CON launched its prefabricated business in October last year​, in collaboration with Integrated Project Services (IPS).

This latest collaboration with Pall delivers “a complete, reproducible, scalable facility solution that is easy to place or relocate, as well as clean, sanitise and even repurpose,” ​said Pall Biotech vice president and general manager, Mario Philips, in an emailed statement.

“This solution addresses customer demand for higher efficiencies while enjoying more flexibility through scale-out and localisation of manufacturing,” ​he added.

According to G-CON, the predesigned PODs, which are integrated with process piping, as well as heating and air conditioning systems, are inherently flexible – the cleanrooms can support multiple products and be repurposed after use.

G-CON and Pall’s offering will compete with GE Healthcare Life Sciences’ KUBio modular bioprocessing facility, which as of April this year​ supports the manufacture of viral vector vaccines.

Related news

Show more

Related products

Process optimization for mAb commercial manufacturing

Process optimization for mAb commercial manufacturing

Content provided by Catalent | 01-Jun-2023 | Product Presentation

Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring...

Related suppliers